Abstract
Ex vivo analysis of signaling pathways operating in tumor tissue is complicated by the three-dimensional structure, in particular by stroma–epithelial interactions. Studies performed with pure populations of tumor cells usually do not take into account this issue. One possibility to preserve the tissue architecture is the use of tumor slices. However, diffusion of oxygen and nutrients may become limiting factors, resulting in decreased cell viability and change of tissue morphology, especially after long-term incubation of slices. By using precision cut slices of defined thickness, we were able to establish culture conditions for tumor material obtained from MMTV-neu transgenic mice, which allow the study of the action of cytokines and cytotoxic drugs for up to 24 h. A slice thickness of 160 μm was found to be optimal for viability and handling of material. These slices were highly responsive to the action of the cytokine IFN-γ, as evident form the increase of pY701 STAT1, detected by both immunohistochemistry and western blotting, and by the increase of mRNA levels of the IFN-γ response genes IRF-1, SOCS-1, and STAT1, analyzed by reverse transcriptase–polymerase chain reaction. Furthermore, induction of apoptosis and increase of DNA damage could be monitored after treatment with IFN-γ or doxorubicin. The slices were also a convenient source for the establishment of explant cultures of tumor epithelial cells. It is concluded that cultivation of precision-cut tumor slices provides a convenient way for the ex vivo molecular analysis of MMTV-neu tumor tissue under conditions which closely simulate the situation in vivo and can provide an alternative to in vivo experiments.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blauer M.; Tammela T. L.; Ylikomi T. A novel tissue-slice culture model for non-malignant human prostate. Cell Tissue Res. 332: 489–498; 2008. doi:10.1007/s00441-008-0602-z.
Campbell M. J.; Wollish W. S.; Lobo M.; Esserman L. J. Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse. In Vitro Cell Dev. Biol. Anim. 38: 326–333; 2002. doi:10.1290/1071-2690(2002)038<0326:EAFCLD>2.0.CO;2.
Guy C. T.; Webster M. A.; Schaller M.; Parsons T. J.; Cardiff R. D.; Muller W. J. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. U S A. 89: 10578–10582; 1992. doi:10.1073/pnas.89.22.10578.
Haffner M. C.; Jurgeit A.; Berlato C.; Geley S.; Parajuli N.; Yoshimura A.; Doppler W. Interaction and functional interference of glucocorticoid receptor and SOCS1. J. Biol. Chem. 283: 22089–22096; 2008. doi:10.1074/jbc.M801041200.
Haffner M. C.; Petridou B.; Peyrat J. P.; Revillion F.; Muller-Holzner E.; Daxenbichler G.; Marth C.; Doppler W. Favorable prognostic value of SOCS2 and IGF-I in breast cancer. BMC Cancer 7: 136; 2007. doi:10.1186/1471-2407-7-136.
Jurgeit A.; Berlato C.; Obrist P.; Ploner C.; Massoner P.; Schmolzer J.; Haffner M. C.; Klocker H.; Huber L. A.; Geley S.; Doppler W. Insulin-like growth factor-binding protein-5 enters vesicular structures but not the nucleus. Traffic 8: 1815–1828; 2007. doi:10.1111/j.1600-0854.2007.00655.x.
Kass L.; Erler J. T.; Dembo M.; Weaver V. M. Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis. Int. J. Biochem. Cell. Biol. 39: 1987–1994; 2007. doi:10.1016/j.biocel.2007.06.025.
Kendrick J. E.; Estes J. M.; Straughn J. M. Jr.; Alvarez R. D.; Buchsbaum D. J. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its therapeutic potential in breast and gynecologic cancers. Gynecol. Oncol. 106: 614–621; 2007. doi:10.1016/j.ygyno.2007.05.035.
Kendrick J. E.; Straughn J. M. Jr.; Oliver P. G.; Wang W.; Nan L.; Grizzle W. E.; Stockard C. R.; Alvarez R. D.; Buchsbaum D. J. Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model. Gynecol. Oncol. 108: 591–597; 2008. doi:10.1016/j.ygyno.2007.11.039.
Kern M. A.; Haugg A. M.; Eiteneuer E.; Konze E.; Drebber U.; Dienes H. P.; Breuhahn K.; Schirmacher P.; Kasper H. U. Ex vivo analysis of antineoplastic agents in precision-cut tissue slices of human origin: effects of cyclooxygenase-2 inhibition in hepatocellular carcinoma. Liver Int. 26: 604–612; 2006. doi:10.1111/j.1478-3231.2006.01268.x.
Kirby T. O.; Rivera A.; Rein D.; Wang M.; Ulasov I.; Breidenbach M.; Kataram M.; Contreras J. L.; Krumdieck C.; Yamamoto M.; Rots M. G.; Haisma H. J.; Alvarez R. D.; Mahasreshti P. J.; Curiel D. T. A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity. Clin. Cancer Res. 10: 8697–8703; 2004. doi:10.1158/1078-0432.CCR-04-1166.
Kolodkin-Gal D.; Zamir G.; Edden Y.; Pikarsky E.; Pikarsky A.; Haim H.; Haviv Y. S.; Panet A. Herpes simplex virus type 1 preferentially targets human colon carcinoma: role of extracellular matrix. J. Virol. 82: 999–1010; 2008. doi:10.1128/JVI.01769-07.
Kunz-Schughart L. A. Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor. Cell Biol. Int. 23: 157–161; 1999. doi:10.1006/cbir.1999.0384.
Kurz E. U.; Douglas P.; Lees-Miller S. P. Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species. J. Biol. Chem. 279: 53272–53281; 2004. doi:10.1074/jbc.M406879200.
Lang D. S.; Droemann D.; Schultz H.; Branscheid D.; Martin C.; Ressmeyer A. R.; Zabel P.; Vollmer E.; Goldmann T. A novel human ex vivo model for the analysis of molecular events during lung cancer chemotherapy. Respir. Res. 8: 43; 2007. doi:10.1186/1465-9921-8-43.
Lerche-Langrand C.; Toutain H. J. Precision-cut liver slices: characteristics and use for in vitro pharmaco-toxicology. Toxicology 153: 221–253; 2000. doi:10.1016/S0300-483X(00)00316-4.
Levy D. E.; Darnell J. E. Jr. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3: 651–662; 2002. doi:10.1038/nrm909.
Lollini P. L.; Cavallo F.; Nanni P.; Forni G. Vaccines for tumour prevention. Nat. Rev. Cancer 6: 204–216; 2006. doi:10.1038/nrc1815.
Olinga P.; Groen K.; Hof I. H.; De Kanter R.; Koster H. J.; Leeman W. R.; Rutten A. A.; Van Twillert K.; Groothuis G. M. Comparison of five incubation systems for rat liver slices using functional and viability parameters. J. Pharmacol. Toxicol. Methods 38: 59–69; 1997. doi:10.1016/S1056-8719(97)00060-9.
Parrish A. R.; Gandolfi A. J.; Brendel K. Precision-cut tissue slices: applications in pharmacology and toxicology. Life Sci. 57: 1887–1901; 1995. doi:10.1016/0024-3205(95)02176-J.
Parrish A. R.; Sallam K.; Nyman D. W.; Orozco J.; Cress A. E.; Dalkin B. L.; Nagle R. B.; Gandolfi A. J. Culturing precision-cut human prostate slices as an in vitro model of prostate pathobiology. Cell Biol. Toxicol. 18: 205–219; 2002. doi:10.1023/A:1015567805460.
Pei X. F.; Noble M. S.; Davoli M. A.; Rosfjord E.; Tilli M. T.; Furth P. A.; Russell R.; Johnson M. D.; Dickson R. B. Explant-cell culture of primary mammary tumors from MMTV-c-Myc transgenic mice. In Vitro Cell Dev. Biol. Anim. 40: 14–21; 2004. doi:10.1290/1543-706X(2004)40<14:ECOPMT>2.0.CO;2.
Piechocki M. P. A stable explant culture of HER2/neu invasive carcinoma supported by alpha-smooth muscle actin expressing stromal cells to evaluate therapeutic agents. BMC Cancer 8: 119; 2008. doi:10.1186/1471-2407-8-119.
Schmidt K.; Werner-felmayer G.; Mayer B.; Werner E. R. Preferential inhibition of inducible nitric oxide synthase in intact cells by the 4-amino analogue of tetrahydrobiopterin. Eur. J. Biochem. 259: 25–31; 1999. doi:10.1046/j.1432-1327.1999.00003.x.
Shekhar M. P.; Pauley R.; Heppner G. Host microenvironment in breast cancer development: extracellular matrix–stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res. 5: 130–135; 2003. doi:10.1186/bcr580.
Tlsty T. D.; Coussens L. M. Tumor stroma and regulation of cancer development. Annu. Rev. Pathol. 1: 119–150; 2006. doi:10.1146/annurev.pathol.1.110304.100224.
Toutain H. J.; Moronvalle-Halley V.; Sarsat J. P.; Chelin C.; Hoet D.; Leroy D. Morphological and functional integrity of precision-cut rat liver slices in rotating organ culture and multiwell plate culture: effects of oxygen tension. Cell Biol. Toxicol. 14: 175–190; 1998. doi:10.1023/A:1007458408863.
Ursini-Siegel J.; Schade B.; Cardiff R. D.; Muller W. J. Insights from transgenic mouse models of ERBB2-induced breast cancer. Nat. Rev. Cancer 7: 389–397; 2007. doi:10.1038/nrc2127.
van der Kuip H.; Murdter T. E.; Sonnenberg M.; McClellan M.; Gutzeit S.; Gerteis A.; Simon W.; Fritz P.; Aulitzky W. E. Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment. BMC Cancer 6: 86; 2006. doi:10.1186/1471-2407-6-86.
Woods A.; Sherwin T.; Sasse R.; MacRae T. H.; Baines A. J.; Gull K. Definition of individual components within the cytoskeleton of Trypanosoma brucei by a library of monoclonal antibodies. J. Cell Sci. 93Pt 3: 491–500; 1989.
Acknowledgment
Grant support: Integrated Center for Research and Therapy (IFTZ) of Innsbruck Medical University (W. Doppler); Doctorate program MCBO funded by the Austrian Science Fund FWF (N. Parajuli). We would like to thank Martina Chamson, Anto Nogalo, Sonja Philipp and Stefanie Faserl for their excellent technical assistance and Dr. Karl Maly for his help in the calibration of thickness of tumor slices.
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor: J. Denry Sato
Rights and permissions
About this article
Cite this article
Parajuli, N., Doppler, W. Precision-cut slice cultures of tumors from MMTV-neu mice for the study of the ex vivo response to cytokines and cytotoxic drugs. In Vitro Cell.Dev.Biol.-Animal 45, 442–450 (2009). https://doi.org/10.1007/s11626-009-9212-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-009-9212-7